Dog Pain Management: Surgical and Osteoarthritis Treatment Insights

Managing Your Dog’s Pain: New Insights from Surgical and Osteoarthritis Research

Pain management is a foundational pillar of canine veterinary care, influencing recovery and quality of life. Two recent studies offer concrete data on improving outcomes, from surgical procedures like spaying to the chronic pain of osteoarthritis. The first demonstrates how a specific preoperative medication stabilizes anesthesia, while the second examines a potential adjunct therapy that may reduce reliance on daily medications.

Pre-Surgical Tapentadol Deepens Anesthesia, Eases Recovery

A team from the University of Messina, University of Parma, and UFMG in Brazil assigned 66 healthy female dogs to one of three pain management protocols before elective spaying. One group received standard pain relief, another got tapentadol alone, and a third received a combination. All dogs were anesthetized with propofol and sevoflurane.

Dogs that received tapentadol before surgery needed less anesthetic to maintain an appropriate depth during the procedure. Their anesthesia was more stable in response to surgical stimulation, measured by parameters like heart rate and blood pressure. After surgery, these dogs experienced higher sedation for about two hours, which then resolved. This smoother, more controlled emergence from anesthesia can reduce stress and the risk of injury. The researchers also measured plasma serotonin, finding lower levels in the tapentadol groups postoperatively. Serotonin is involved in pain perception and mood; modulating it may be one way tapentadol improves perioperative comfort.

Laser Therapy Shows Promise for Reducing Osteoarthritis Drug Doses

For chronic conditions like osteoarthritis (OA), long-term medication use raises concerns about side effects. A 2025 evidence summary by Ciar Fitzpatrick reviewed whether adding concurrent laser treatment to standard non-steroidal anti-inflammatory drugs (NSAIDs) is more effective for dogs with OA. The analysis found one randomized controlled trial on the subject.

In that trial, dogs receiving laser therapy alongside NSAIDs saw significant improvements. Their Helsinki chronic pain scores and lameness scores improved more than the control group on NSAIDs alone. Notably, the laser therapy group also required a lower overall dose of NSAIDs to achieve this effect. Fitzpatrick categorizes the strength of this evidence as weak, due to being based on a single study. The conclusion is not that laser therapy is superior, but that it may be a useful tool for reducing clinical signs and potentially lowering NSAID requirements. More robust clinical studies are necessary to confirm these preliminary findings.

Mechanisms of Action: From Receptor Binding to Cellular Energy

These studies highlight two distinct biological pathways for managing pain. Tapentadol is an opioid analgesic with a dual mechanism. It binds to mu-opioid receptors in the brain and spinal cord to blunt pain signals, but it also inhibits the reuptake of norepinephrine. This second action helps modulate the body’s stress response and contributes to the serotonergic effects observed in the Italian study. The result is a multi-faceted approach to pain that can enhance the stability of general anesthesia.

Laser therapy, or photobiomodulation, works on a cellular level. Specific wavelengths of light are absorbed by mitochondrial chromophores, which are light-sensitive components within a cell’s energy factories. This absorption is thought to increase cellular energy (ATP) production, reduce oxidative stress, and decrease inflammatory mediators like prostaglandins. By reducing inflammation and promoting healing at the joint, it addresses the source of OA pain, which may explain the reduced need for systemic NSAIDs. Managing a dog’s exercise impact remains a cornerstone of OA management alongside such treatments.

Applying Evidence to Veterinary Practice and Home Care

For pet owners, these findings translate into more informed conversations with their veterinary team. For upcoming surgeries like spaying, ask about the clinic’s perioperative pain management plan. Research supports protocols that include pre-emptive analgesia—administering pain medication before the surgical incision—to minimize central pain sensitization. The study on tapentadol provides evidence for one effective option in this strategy.

For dogs with osteoarthritis, the laser therapy evidence, while preliminary, suggests it’s reasonable to discuss it as a possible adjunct to a management plan that includes weight control, tailored exercise as outlined in our canine hip dysplasia guide, and medications. A multi-modal approach often yields the best results. It is also critical to ensure a dog’s overall health supports recovery; for instance, understanding how sleep quality links to health underscores the importance of restful recovery periods.

Always follow veterinary guidance on medication. Never adjust NSAID doses or add supplements without consultation, as interactions and side effects can occur.

Conclusion

Modern canine pain management is moving toward personalized, multi-modal strategies backed by specific research. Evidence shows that preoperative tapentadol can improve surgical experiences, while laser therapy may offer a supplemental tool for chronic joint disease. Ongoing research will further refine how these and other modalities are best used to ensure canine comfort and welfare.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42076750/
https://pubmed.ncbi.nlm.nih.gov/42006385/